Issue 22, 2023, Issue in Progress

Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents

Abstract

Correction for ‘CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents’ by Cong-Min Peng et al., RSC Adv., 2023, 13, 13169–13176, https://doi.org/10.1039/D3RA01927F.

Associated articles

Article information

Article type
Correction
Submitted
09 May 2023
Accepted
09 May 2023
First published
16 May 2023
This article is Open Access
Creative Commons BY license

RSC Adv., 2023,13, 14878-14878

Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents

C. Peng, S. Wang, Y. Hwang, W. Sun, L. Chiu, Y. Liu, Y. Lai and H. Lee, RSC Adv., 2023, 13, 14878 DOI: 10.1039/D3RA90046K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements